Search
for
Sort by
Research 31–60 of 111
- Identification and Characterization of Two Se6OMTs from Stephania epigaea Offer Novel Insights into the Biosynthetic Pathway of Cepharanthine
- Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
- Safety and Efficacy of Oral administrated Cepharanthine in Non-hospitalized, asymptomatic or mild COVID-19 patients: A Double-blind, Randomized, Placebo-controlled Trial
- Preparation and Evaluation of Self-emulsifying Drug Delivery System (SEDDS) of Cepharanthine
- Genome assembly of Stephania longa provides insight into cepharanthine biosynthesis
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Bisbenzylisoquinoline Alkaloids from<i>Stephania cepharantha</i>and their Effects on Proliferation of Cultured Cells from the Murine Hair Apparatus
- Recovery From Alopecia After COVID-19
- Proximate Composition, Mineral analysis and Phytochemical Characterization of an Ethnomedicinal Plant Sphenodesme involucrata var. paniculata (C.B. Clarke) Munir
- Seventeen Cases of Alopecia Areata: Combination of SADBE Topical Immunotherapy with Other Therapies
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Bis-Benzylisoquinoline Alkaloids Inhibit Porcine Epidemic Diarrhea Virus In Vitro and In Vivo
- Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical <i>in silico/in vitro</i> screening methods
- Expression relationship between microRNA and transcription factors in Stephania japonica
- Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Antiviral Drugs Screening for Swine Acute Diarrhea Syndrome Coronavirus
- DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHES
- Amino acid–derived defense metabolites from plants: A potential source to facilitate novel antimicrobial development
- Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
- Natural Products as A Promising Therapy for SARS COV-2; An Overview
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking
- COVID-19: How Effective Are the Repurposed Drugs and Novel Agents in Treating the Infection?
- Virtual Screening of Potential Inhibitors for SARS-CoV-2 Main Protease
- Alopecia areata: An update
- Advances in the management of alopecia areata
- Induction of hair follicle dermal papilla cell properties in human induced pluripotent stem cell-derived multipotent LNGFR(+)THY-1(+) mesenchymal cells
- Guidelines for the management of androgenetic alopecia (2010)